# Safety and Efficacy of TCD-10023 (Ultimaster) Drug-eluting Stent in STEMI Patients - MASTER Study

Study · id `cardio:ct-nct02828683` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02828683](<https://clinicaltrials.gov/study/NCT02828683>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02828683

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It plans to enroll 500 participants.

## Technical summary

Registry record NCT02828683. Randomized; single masking; primary purpose treatment. Start 2013-07 (registry gives no type); primary completion 2016-07 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 500 participants (planned count; ClinicalTrials.gov record NCT02828683, source copy `cardio:ctgov-nct02828683-2018-07-05`, retrieved 2026-10-26)
- Start date: 2013-07 (registry gives no type) (ClinicalTrials.gov record NCT02828683, source copy `cardio:ctgov-nct02828683-2018-07-05`, retrieved 2026-10-26)
- Primary completion: 2016-07 (actual) (ClinicalTrials.gov record NCT02828683, source copy `cardio:ctgov-nct02828683-2018-07-05`, retrieved 2026-10-26)
- Completion: 2018-05 (actual) (ClinicalTrials.gov record NCT02828683, source copy `cardio:ctgov-nct02828683-2018-07-05`, retrieved 2026-10-26)
- Countries: Brazil; Italy; North Macedonia; Serbia; Spain (ClinicalTrials.gov record NCT02828683, source copy `cardio:ctgov-nct02828683-2018-07-05`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02828683-2018-07-05`, retrieved 2026-10-26)

## The registry's words

- Brief title: Safety and Efficacy of TCD-10023 (Ultimaster) Drug-eluting Stent in STEMI Patients - MASTER Study
- Acronym: MASTER
- Condition: Acute ST Segment Elevation Myocardial Infarction
- Intervention (Device): PCI in patients with ST-elevation myocardial infarction
- Intervention (Device): PCI in patients with ST-elevation myocardial infarction
- Lead sponsor: Terumo Europe N.V.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry condition terms include this condition: ST-elevation heart attack (STEMI) (`cardio:stemi`)
- Registry lists this organization as the lead sponsor: Terumo Europe N.V. (`cardio:org-terumo-europe-n-v`)

## Provenance

Content hash: ce27f31f7c3f831d43509c3780dd717a098db5fd74bd39ec7b7c180daf2c11a5
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
